tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

XLO Stock Latest News

Xilio Therapeutics Advances with Phase 2 Trial Data
Company AnnouncementsXilio Therapeutics Advances with Phase 2 Trial Data
9m ago
8K
XLO
Xilio reports results from ongoing Phase 2 clinical trial of vilastobart
PremiumThe Fly
Xilio reports results from ongoing Phase 2 clinical trial of vilastobart
28m ago
XLO
Xilio Therapeutics Secures $25M Investment from Gilead
PremiumCompany Announcements
Xilio Therapeutics Secures $25M Investment from Gilead
1M ago
8K
XLO
Xilio Therapeutics to present initial Phase 2 data for XTX101 at ASCO GI
PremiumThe Fly
Xilio Therapeutics to present initial Phase 2 data for XTX101 at ASCO GI
1M ago
XLO
Xilio Therapeutics appoints Caroline Hensley as CLO
PremiumThe Fly
Xilio Therapeutics appoints Caroline Hensley as CLO
1M ago
XLO
MCRB
Xilio Therapeutics Reports Q3 2024 Progress and Financials
PremiumCompany AnnouncementsXilio Therapeutics Reports Q3 2024 Progress and Financials
2M ago
XLO
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
Premium
Company Announcements
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
3M ago
8K
XLO
Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
Premium
The Fly
Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
3M ago
XLO
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
PremiumThe Fly
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
3M ago
XLO
Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)
PremiumThe Fly
Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)
3M ago
XLO
Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year
PremiumThe Fly
Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year
6M ago
XLO
Xilio Therapeutics Enhances Board with Two New Directors
PremiumCompany Announcements
Xilio Therapeutics Enhances Board with Two New Directors
7M ago
8K
XLO
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
PremiumThe FlyXilio Therapeutics expects cash to fund operations into Q2 of 2025
8M ago
XLO
GILD
Xilio Therapeutics reports Q1 EPS (62c) vs (83c) last year
Premium
The Fly
Xilio Therapeutics reports Q1 EPS (62c) vs (83c) last year
8M ago
XLO
Xilio Therapeutics files to sell 17.58M shares of common stock for holders
Premium
The Fly
Xilio Therapeutics files to sell 17.58M shares of common stock for holders
9M ago
XLO
Fly Insider: Xilio, Aerovate among week’s notable insider trades
PremiumThe Fly
Fly Insider: Xilio, Aerovate among week’s notable insider trades
10M ago
XLO
ALDX
Xilio Therapeutics reports Q4 EPS (64c), consensus (64c)
PremiumThe Fly
Xilio Therapeutics reports Q4 EPS (64c), consensus (64c)
10M ago
XLO
Xilio Therapeutics Strikes Lucrative Deal with Gilead Sciences
PremiumCompany Announcements
Xilio Therapeutics Strikes Lucrative Deal with Gilead Sciences
10M ago
8K
XLO
Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal
PremiumThe Fly
Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal
10M ago
XLO
GILD
Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301
PremiumThe FlyXilio Therapeutics, Gilead announce exclusive license agreement for XTX301
10M ago
XLO
GILD
Xilio Therapeutics announces $11.3M private placement equity financing
Premium
The Fly
Xilio Therapeutics announces $11.3M private placement equity financing
10M ago
XLO
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
Premium
The Fly
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
10M ago
XLO
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >